logo

For the Inventor, By the Inventor

Kagoshima, Japan

Shin Nippon Biomedical Laboratories, Ltd.

Calculating rank
USPTO Granted Patents = 36

% Expired Patents = 19.4



Trademarks = 3

Forward Citations = 298

Loading Chart...
Loading Chart...

20 inventors (with patents filed for the assignee):

goldMedal Shunji Haruta (19 out of 22 patents)

silverMedal Ryoichi Nagata (17 out of 17 patents)

bronzeMedal Tatsuo Tsutsui (6 out of 15 patents)

4.  Takefumi Gemba (4 out of 9 patents)

5.  Hidetoshi Yamashita (2 out of 2 patents)

6.  Nobuyuki Suzuki (2 out of 2 patents)

7.  Takashi Hanafusa (2 out of 4 patents)

8.  Toshikazu Oki (2 out of 61 patents)

9.  Genji Satoyoshi (2 out of 2 patents)

10.  Hideaki Mishima (2 out of 2 patents)

11.  Yutaka Kawakami (1 out of 13 patents)

12.  Yusuke Torikai (1 out of 1 patent)

13.  Ikumi Shiga (1 out of 1 patent)

14.  Masatoshi Kashima (1 out of 1 patent)

15.  Hiroaki Magotani (1 out of 1 patent)


Core Competencies:
Intranasal Delivery Devices
Pharmaceutical Compositions
Medicine Dispensing Device
Powder Formulation
Vaccine Compositions
Chiral Nucleic Acid Adjuvant
Micro-Encapsulated Feed
Animal Experiment Systems
Transnasal Application
Nasal Administration
Pharmacokinetics
Primate Restraint Device

36 patents:

1. 12503841 - Urine scattering prevention device (2025-12-23),
2. 12478581 - Powder formulation for intranasal administration, and manufacturing method thereof (2025-11-25),
3. 12343472 - Powder preparation, cartridge, and device (2025-07-01),
4. 12246130 - Medicine dispensing device and method for manufacturing same (2025-03-11),
5. 12137706 - Micro-encapsulated aquaculture feed (2024-11-12),
6. 12102754 - Intranasal delivery devices (2024-10-01),
7. 11872314 - Pharmaceutical compositions (2024-01-16),
8. 11744967 - Intranasal delivery devices (2023-09-05),
9. 11559640 - Medicine storage cartridge with nozzle, sprayer therefor, and powdered medicine dispensing device for nasal cavity (2023-01-24),
10. 11311615 - Vaccine compositions (2022-04-26),
11. 10792253 - Pharmaceutical compositions (2020-10-06),
12. 10463723 - Methods and compositions for intranasal delivery (2019-11-05),
13. 10322173 - Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent (2019-06-18),
14. 10293123 - Test substance administration system for animal experiment (2019-05-21),
15. 10195139 - Preparation for transnasal application (2019-02-05),
Company Overview
Shin Nippon Biomedical Laboratories, Ltd. is a prominent organization based in Kagoshima, Japan, specializing in the development and manufacturing of pharmaceutical products and medical devices. The company focuses on innovative research in the fields of biomedicine and healthcare, aiming to enhance therapeutic solutions and improve patient outcomes. With a commitment to advancing medical technology, Shin Nippon Biomedical Laboratories plays a significant role in the life sciences sector, contributing to both domestic and international healthcare advancements.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

36 Patents

#2 in Kagoshima

#2,102 in Japan

#18,756 in the World

Kagoshima, JP
Kagoshima, Japan

Shin Nippon Biomedical Laboratories, Ltd.

Forward Citations = 298

20 inventors:

goldMedal Shunji Haruta (19 out of 22 patents)

silverMedal Ryoichi Nagata (17 out of 17 patents)

bronzeMedal Tatsuo Tsutsui (6 out of 15 patents)

4.  Takefumi Gemba (4 out of 9 patents)

5.  Hidetoshi Yamashita (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Shin Nippon Biomedical Laboratories, Ltd.. Retrieved from https://idiyas.com/company/shin-nippon-biomedical-laboratories

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…